Skip to main content
    T

    TuHURA Biosciences Inc (HURA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.33
    -0.06 (-4.32%)

    Market Cap: $88.58M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    TuHURA Biosciences Inc (HURA) Earnings: Report Dates and Results

    Updated Nov 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    TuHURA Biosciences (HURA) is expected to report earnings on Mar 29, 2027. In the quarter ended Sep 30, 2026, TuHURA Biosciences reported EPS of -$0.10, above the -$0.14 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    29%(8/28)
    Avg Surprise
    -58.95%
    Streak
    2 Q

    Upcoming Estimates

    Reports Mar 29, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.14
    Range-$0.16 - -$0.13
    7 analysts
    Revenue Consensus
    N/A
    RangeN/A
    5 analysts

    Next Report

    HURA has an expected report date of Mar 29, 2027.

    Earnings History

    Of the 28 quarters below that had an estimate, HURA beat 8, missed 18 and matched 2. The widest gap in the table came in the quarter ended Mar 31, 2023, when EPS landed 921.05% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.10-$0.14-$0.14 - -$0.12+28.57%BeatN/A21 up, 0 downNov 13, 2026
    Jun 30, 2026-$0.14-$0.15-$0.21 - -$0.12+6.67%BeatN/A3N/AAug 13, 2026
    Mar 31, 2026-$0.13-$0.11-$0.12 - -$0.10-18.18%MissN/A21 up, 0 downMay 15, 2026
    Dec 31, 2025-$0.16-$0.12-$0.15 - -$0.12-35.92%MissN/A21 up, 1 downMar 31, 2026
    Sep 30, 2025-$0.14-$0.15-$0.15 - -$0.15+6.67%BeatN/A20 up, 2 downNov 14, 2025
    Jun 30, 2025-$0.21-$0.13-$0.14 - -$0.13-61.54%MissN/A20 up, 1 downAug 14, 2025
    Mar 31, 2025-$0.15-$0.13N/A-15.38%MissN/A20 up, 0 downMay 15, 2025
    Dec 31, 2024-$0.14-$0.60N/A+76.67%BeatN/A10 up, 0 downFeb 26, 2025
    Sep 30, 2024-$3.00-$3.15-$3.15 - -$3.15+4.69%BeatN/A10 up, 0 downNov 14, 2024
    Mar 31, 2024-$1.58N/AN/AN/AN/AN/AN/AN/AMay 14, 2024
    Dec 31, 2023-$8.27N/AN/AN/AN/AN/AN/AN/AFeb 15, 2024
    Sep 30, 2023-$63.91N/AN/AN/AN/AN/AN/AN/ANov 14, 2023
    Jun 30, 2023-$68.25-$36.92N/A-84.86%MissN/AN/AN/ASep 19, 2023
    Mar 31, 2023-$1.94-$0.19N/A-921.05%MissN/AN/AN/AJun 29, 2023
    Dec 31, 2022-$2.10-$8.00N/A+73.75%BeatN/AN/AN/AMar 31, 2023
    Sep 30, 2022-$3.50N/AN/AN/AN/AN/AN/AN/ANov 9, 2022
    Jun 30, 2022-$0.04-$0.02N/A-100.00%MissN/AN/AN/ASep 27, 2022
    Mar 31, 2022-$0.11-$0.11N/A-3.09%MissN/AN/AN/AJun 29, 2022
    Dec 31, 2021-$0.12-$0.17N/A+30.76%BeatN/AN/AN/AMar 30, 2022
    Sep 30, 2021-$0.25-$0.14N/A-74.46%MissN/AN/AN/ANov 15, 2021
    Jun 30, 2021-$0.21-$0.16N/A-29.23%MissN/AN/AN/ASep 29, 2021
    Mar 31, 2021-$0.23-$0.18N/A-26.03%MissN/AN/AN/AJun 29, 2021
    Dec 31, 2020-$0.22-$0.14N/A-54.39%MissN/AN/AN/AMar 30, 2021
    Sep 30, 2020-$1.33-$0.06N/AN/AN/AN/AN/AN/ANov 13, 2020
    Jun 30, 2020-$0.34-$0.11N/A-209.09%MissN/AN/AN/ASep 21, 2020
    Mar 31, 2020-$0.17-$0.11N/A-54.55%MissN/AN/AN/AJun 29, 2020
    Dec 31, 2019-$0.15-$0.15N/A0.00%In lineN/AN/AN/AMar 30, 2020
    Sep 30, 2019-$0.21-$0.18N/A-16.67%MissN/AN/AN/ANov 14, 2019
    Jun 30, 2019-$0.83-$0.33N/A-151.52%MissN/AN/AN/ASep 10, 2019
    Mar 31, 2019-$0.67-$0.70N/A+4.29%BeatN/AN/AN/AJun 29, 2019
    Dec 31, 2018-$0.80-$0.70N/A-14.29%MissN/AN/AN/AMar 30, 2019
    Sep 30, 2018-$0.90-$0.80N/A-12.50%MissN/AN/AN/ANov 14, 2018
    Jun 30, 2018-$0.11-$0.11N/A0.00%In lineN/AN/AN/ASep 24, 2018
    Mar 31, 2018-$2,283.79N/AN/AN/AN/AN/AN/AN/AJun 29, 2018
    Dec 31, 2017-$2,494.50N/AN/AN/AN/AN/AN/AN/AMar 30, 2018
    Sep 30, 2017-$3,098.93N/AN/AN/AN/AN/AN/AN/ANov 14, 2017
    Jun 30, 2017-$3,500.00N/AN/AN/AN/AN/AN/AN/ASep 28, 2017
    Mar 31, 2017-$3,142.35N/AN/AN/AN/AN/AN/AN/AJun 29, 2017
    Dec 31, 2016-$2,269.71N/AN/AN/AN/AN/AN/AN/AMar 30, 2017
    Sep 30, 2016-$4,022.18N/AN/AN/AN/AN/AN/AN/ANov 14, 2016
    Last 40 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Jun 30, 2026 was -$0.57, after -$77.26 the year before. It was -$14,092.75 for the year ended Jun 30, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Jun 30, 2026-$0.57N/A
    Jun 30, 2025-$77.26N/A
    Jun 30, 2023-$75.79N/A
    Jun 30, 2022-$0.52N/A
    Jun 30, 2021-$1.99N/A
    Jun 30, 2020-$0.87N/A
    Jun 30, 2019-$3.20N/A
    Jun 30, 2018-$7,877.33N/A
    Jun 30, 2017-$12,934.24N/A
    Jun 30, 2016-$14,092.75N/A

    Frequently Asked Questions About HURA

    When is TuHURA Biosciences's next earnings date?

    TuHURA Biosciences's next earnings report is expected for Mar 29, 2027.

    Did HURA beat earnings estimates last quarter?

    Yes. TuHURA Biosciences reported EPS of -$0.10 for the quarter ended Sep 30, 2026, above the -$0.14 estimate, a 28.57% surprise.

    What EPS do analysts expect from HURA next quarter?

    The consensus EPS estimate for TuHURA Biosciences for the quarter ending Dec 31, 2026 is -$0.14 from 7 analysts, with estimates from -$0.16 to -$0.13.

    How often does HURA beat earnings estimates?

    TuHURA Biosciences beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -1.56%.